G protein-coupled receptor kinase 5, overexpressed in the α-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression

Brain Research

Volumn 1307, Issue , 2010, Pages 134-141

  Liu, Peng ^a   Wang, Xiaoying ^a   Gao, Ning ^a   Zhu, Hua ^a   Dai, Xiaowei ^a   Xu, Yanfeng ^a   Ma, Chunmei ^a   Huang, Lan ^a   Liu, Yali ^a   Qin, Chuan ^a  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Synuclein; Bcl 2; Gene regulation; GRK5; Histone deacetylase

Indexed keywords

ALPHA SYNUCLEIN; G PROTEIN COUPLED RECEPTOR KINASE 5; HISTONE DEACETYLASE; PROTEIN BCL 2; SERINE; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; DISEASE MODELS, ANIMAL; G-PROTEIN-COUPLED RECEPTOR KINASE 5; HISTONE DEACETYLASES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROBLASTOMA; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

MUS MUSCULUS;

EID: 70949099222     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.036     Document Type: Article

References (37)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., and Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12 (1997) 25-31
2. Arawaka S., Wada M., Goto S., Karube H., Sakamoto M., Ren C.H., Koyama S., Nagasawa H., Kimura H., Kawanami T., Kurita K., Tajima K., Daimon M., Baba M., Kido T., Saino S., Goto K., Asao H., Kitanaka C., Takashita E., Hongo S., Nakamura T., Kayama T., Suzuki Y., Kobayashi K., Katagiri T., Kurokawa K., Kurimura M., Toyoshima I., Niizato K., Tsuchiya K., Iwatsubo T., Muramatsu M., Matsumine H., and Kato T. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease. J. Neurosci. 26 (2006) 9227-9238
3. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152 (1998) 879-884
4. Bychkov E.R., Gurevich V.V., Joyce J.N., Benovic J.L., and Gurevich E.V. Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia. Neurobiol. Aging 29 (2008) 379-396
5. Carman C.V., Som T., Kim C.M., and Benovic J.L. Binding and phosphorylation of tubulin by G protein-coupled receptor kinases. J. Biol. Chem. 273 (1998) 20308-20316
6. Chen L., and Feany M.B. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8 (2005) 657-663
7. Freeman J.L., Gonzalo P., Pitcher J.A., Claing A., Lavergne J.P., Reboud J.P., and Lefkowitz R.J. beta 2-Adrenergic receptor stimulated, G protein-coupled receptor kinase 2 mediated phosphorylation of ribosomal protein P2. Biochemistry 41 (2002) 12850-12857
8. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., and Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 (2002) 160-164
9. 3 dopamine receptors. Parkinsonism Relat. Disord. 11 Suppl. 1 (2005) S25-S29
10. Guo J.T., Chen A.Q., Kong Q., Zhu H., Ma C.M., and Qin C. Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Cell Mol. Neurobiol. 28 (2008) 35-47
11. Hartmann A., Michel P.P., Troadec J.D., Mouatt-Prigent A., Faucheux B.A., Ruberg M., Agid Y., and Hirsch E.C. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?. J. Neurochem. 76 (2001) 1785-1793
12. Hartmann A., Troadec J.D., Hunot S., Kikly K., Faucheux B.A., Mouatt-Prigent A., Ruberg M., Agid Y., and Hirsch E.C. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21 (2001) 2247-2255
13. Jellinger K.A. Challenges in neuronal apoptosis. Curr. Alzheimer Res. 3 (2006) 377-391
14. Johnson L.R., Scott M.G., and Pitcher J.A. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol. Cell. Biol. 24 (2004) 10169-10179
15. Joyce J.N., Ryoo H., Gurevich E.V., Adler C., and Beach T. Ventral striatal D (3) receptors and Parkinson's disease. Parkinsonism Relat. Disord. 7 (2001) 225-230
16. Krupnick J.G., and Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 289-319
17. Lefkowitz R.J. G protein-coupled receptors: III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273 (1998) 18677-18680
18. 2+-binding proteins on G protein-coupled receptor kinases. Biochemistry 37 (1998) 13650-13659
19. Martini J.S., Raake P., Vinge L.E., DeGeorge B.R., Chuprun J.K., Harris D.M., Gao E., Eckhart A.D., Pitcher J.A., and Koch W.J. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 12457-12462
20. Mochizuki H., Goto K., Mori H., and Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137 (1996) 120-123
21. 1 dopamine receptors in striatal neurons in Parkinson's disease. Ann. Neurol. 46 (1999) 103-111
22. Offen D., Ziv I., Barzilai A., Gorodin S., Glater E., Hochman A., and Melamed E. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease. Neurochem. Int. 31 (1997) 207-216
23. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P.J., and Haass C. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 275 (2000) 390-397
24. Pitcher J.A., Fredericks Z.L., Stone W.C., Premont R.T., Stoffel R.H., Koch W.J., and Lefkowitz R.J. Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies. J. Biol. Chem. 271 (1996) 24907-24913
25. Pitcher J.A., Freedman N.J., and Lefkowitz R.J. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67 (1998) 653-692
26. Pronin A.N., Carman C.V., and Benovic J.L. Structure-function analysis of G protein-coupled receptor kinase-5. J. Biol. Chem. 273 (1998) 31510-31518
27. Pronin A.N., Morris A.J., Surguchov A., and Benovic J.L. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275 (2000) 26515-26522
28. 2 receptor is elevated in the striatum of Parkinson's disease. Mov. Disord. 13 (1998) 788-797
29. Sakamoto M., Arawaka S., Hara S., Sato H., Cui C., Machiya Y., Koyama S., Wada M., Kawanami T., Kurita K., and Kato T. Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells. Biochem. Biophys. Res. Commun. 384 (2009) 378-382
30. Sorriento D., Ciccarelli M., Santulli G., Campanile A., Altobelli G.G., Cimini V., Galasso G., Astone D., Piscione F., Pastore L., Trimarco B., and Iaccarino G. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 17818-17823
31. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. alpha-Synuclein in Lewy bodies. Nature 388 (1997) 839-840
32. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6469-6473
33. Takai N., Nakanishi H., Tanabe K., Nishioku T., Sugiyama T., Fujiwara M., and Yamamoto K. Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J. Neurosci. Res. 54 (1998) 214-222
34. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274 (1999) 8531-8538
35. Tatton W.G., Chalmers-Redman R., Brown D., and Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53 Suppl. 3 (2003) S61-S70
36. Tompkins M.M., Basgall F.J., Zanrini E., and Hill W.D. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150 (1997) 119-131
37. Yamada M., Iwatsubo T., Mizuno Y., and Mochizuki H. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J. Neurochem. 91 (2004) 451-461